Biocon has inaugurated its first US manufacturing facility following a $30 million investment, the company said. The facility, operated by Biocon’s subsidiary BGI, has a production capacity of 2 billion tablets. Here’s all we know…
Biocon has inaugurated its first US manufacturing facility following a $30 million investment, the company said. The facility, operated by Biocon’s subsidiary BGI, has a production capacity of 2 billion tablets. Here’s all we know… by Soban News (international And National News)
